About TheraPharm Deutschland
TheraPharm Deutschland is a Healthcare company based in Giessen (Germany) founded in 1999, and was acquired by Telix Pharma in November 2020. Monoclonal antibody conjugates are developed for cancer immunotherapy. The company was acqui-hired. Its focus areas include Life Sciences, Oncology, Drugs and Pan Cancer.
Company details
TheraPharm Deutschland was founded in 1999 in Giessen, Germany, as a biopharma entity. Focus is placed on monoclonal antibody conjugates for cancer immunotherapy, alongside immunosuppressive therapy, radioimmunotherapy, and diagnostics. Partnerships are maintained with Scintec Diagnostics in Switzerland and Azacycles in the Czech Republic to support these operations. Activities are centered in the oncology and diagnostic sectors.
- Headquarters Giessen, Germany
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website therapharm-deutschland.de
- Acquired by Telix Pharma (Nov 2020)
- Investors
- Acquired byTelix Pharma
(Nov 2020)
Investors in TheraPharm Deutschland
TheraPharm Deutschland has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Telix Pharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Theranostic radiopharmaceuticals are developed for cancer imaging and therapy. | 2015 | telixpharma.com | Melbourne, Australia |
Investor details for TheraPharm Deutschland
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of TheraPharm Deutschland
1 people are tracked at TheraPharm Deutschland (1 in leadership).
| Name | Role | Group |
|---|---|---|
Klaus Bosslet | Managing Director | Leadership |
Complete people profiles for TheraPharm Deutschland
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of TheraPharm Deutschland
2 dated milestones of TheraPharm Deutschland across 21 years, from founding to its latest funding, stage changes and deals.
- Founded TheraPharm Deutschland is founded.
- Exit Acquired by Telix Pharma.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about TheraPharm Deutschland
TheraPharm Deutschland was founded in 1999.
TheraPharm Deutschland is headquartered in Giessen, Germany. It is registered at Giessen, Hesse, Germany.
TheraPharm Deutschland was founded in 1999 in Giessen, Germany, as a biopharma entity. Focus is placed on monoclonal antibody conjugates for cancer immunotherapy, alongside immunosuppressive therapy, radioimmunotherapy, and diagnostics. Partnerships are maintained with Scintec Diagnostics in Switzerland and Azacycles in the Czech Republic to support these operations. Activities are centered in the oncology and diagnostic sectors.
TheraPharm Deutschland has 1 investor. Key investors include Telix Pharmaceuticals.
Yes. TheraPharm Deutschland was acquired by Telix Pharma in November 2020.